JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Nemiralisib (GSK-2269557) is a novel, potent and selective PI3Kdelta inhibitor with pKi of 9.9. It is active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation. PI3Kdelta is highly enriched in leukocytes, making it an attractive target for the treatment of inflammatory conditions, such as asthma, 6 chronic obstructive pulmonary disease (COPD), and autoimmune diseases. GSK-2269557 is is currently in clinical trials for the treatment of respiratory diseases such as asthma and COPD.
References: J Med Chem. 2015 Sep 24; 58(18):7381-99.
Related CAS#: 1254036-77-5 (HCl); 1254036-71-9 (free base)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!